SCLC,Extensive Stage Clinical Trials
0 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 2
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
SCLC,Extensive StageSLFN11-positive
ETOP IBCSG Partners Foundation44 enrolled18 locationsNCT05718323
Recruiting
Phase 2
Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy
SCLC,Extensive Stage
Tang-Du Hospital32 enrolled1 locationNCT07141264
Recruiting
Phase 1
Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
SCLC,Extensive Stage
RayzeBio, Inc.49 enrolled15 locationsNCT05595460
Recruiting
Phase 2
Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC)
SCLC,Extensive Stage
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS60 enrolled12 locationsNCT05623319
Recruiting
Phase 1Phase 2
WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases
Brain MetastasesSCLC,Extensive Stage
Fudan University56 enrolled1 locationNCT06243003